Literature DB >> 2586142

Studies on the relationship between protein kinase C and differentiation of human promyelocytic leukemia cells induced by retinoic acid.

X Z Wu1, G Y Shao, S Chen, X W Wang, Z Y Wang.   

Abstract

We studied the differentiation of acute promyelocytic leukemia (APL) cells in 14 patients with APL. After the induction by retinoic acid (RA) the mature cells rose to 60 +/- 11.8% compared to 0.7 +/- 1% of the control, while the promyelocytes declined to 8.7 +/- 6.4% (93.3 +/- 5.6% in the control group). Protein kinase C (PKC) activity was significantly increased to 149.3 +/- 156.2 pmol/mg per min compared to 47 +/- 40.9 of the control (p less than 0.01). In HL-60 cells, the activity of PKC increased also from 52.3 +/- 35 to 129.2 +/- 64.6 pmol/mg per min (n = 10, p less than 0.01) after the induction of differentiation with RA. If the leukemia cells were pretreated with a kind of PKC inhibitor such as trifluoperazine, the increase of PKC activity was inhibited, and the rate of nitroblue tetrazolium reduction decreased from 89.9 +/- 7.7% to 62 +/- 25% (n = 6, p less than 0.01) and the mature cells reduced from 63.1 +/- 11.7% to 19.7 +/- 12.2% (p less than 0.01). We presumed that the activity of PKC is closely related to the differentiation of human promyelocytic leukemia cells induced by all-trans-retinoic acid.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2586142     DOI: 10.1016/0145-2126(89)90039-8

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  7 in total

1.  Synergistic interactions between differentiation-inducing agents in inhibiting the proliferation of HL-60 human myeloid leukaemia cells in clonogenic micro assays.

Authors:  H T Hassan; A Veit; H R Maurer
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

Review 2.  Tretinoin. A review of its pharmacodynamic and pharmacokinetic properties and use in the management of acute promyelocytic leukaemia.

Authors:  J C Gillis; K L Goa
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

3.  Differential enhancement of leukaemia cell differentiation without elevation of intracellular calcium by plant-derived sesquiterpene lactone compounds.

Authors:  S H Kim; M Danilenko; T S Kim
Journal:  Br J Pharmacol       Date:  2008-08-25       Impact factor: 8.739

4.  New synergistic combinations of differentiation inducing agents in the treatment of acute myeloid leukaemia.

Authors:  H T Hassan; L E Zyada; M H Ragab; J K Rees
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

5.  MiR-223 suppresses cell proliferation by targeting IGF-1R.

Authors:  Cheng You Jia; Hui Hui Li; Xu Chao Zhu; Yi Wei Dong; Da Fu; Qian Lei Zhao; Wei Wu; Xing Zhong Wu
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

Review 6.  Potential anti-cancer activities and mechanisms of costunolide and dehydrocostuslactone.

Authors:  Xuejing Lin; Zhangxiao Peng; Changqing Su
Journal:  Int J Mol Sci       Date:  2015-05-13       Impact factor: 5.923

Review 7.  Put in a "Ca2+ll" to Acute Myeloid Leukemia.

Authors:  Clara Lewuillon; Marie-Océane Laguillaumie; Bruno Quesnel; Thierry Idziorek; Yasmine Touil; Loïc Lemonnier
Journal:  Cells       Date:  2022-02-04       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.